This demonstrates that FXR acetylation is reduced during cholestasis due to increased SIRT1 expression (see Figure 2), which leads to increased FXR target gene expression, as is predicted to ameliorate the cholestasic phenotype. This evidence concerns the gene NR1H4 and cholestasis.